Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Multiple Myeloma × Vorinostat × Clear all

Phase

Status

Completed 12 Terminated 4 Withdrawn 3 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Recurrence 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Hematologic Diseases 1 Graft vs Host Disease 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1

Interventions

Dexamethasone 109 Lenalidomide 77 daratumumab 54 Bortezomib 50 carfilzomib 36 pomalidomide 34 Calcium Dobesilate 32 Cyclophosphamide 26 isatuximab 19 belantamab mafodotin 17 Biopsy 15 Specimen Handling 14 dexamethasone acetate 12 dexamethasone 21-phosphate 12 Melphalan 12 Magnetic Resonance Spectroscopy 12 auricularum 11 selinexor 10 ixazomib 10 fludarabine 10 iberdomide 9 nirogacestat 8 elotuzumab 8 talquetamab 6 fludarabine phosphate 6 trametinib 5 Thalidomide 5 Etoposide 5 venetoclax 4 tocilizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01297764 2026-02-19

QUAD

Hackensack Meridian Health

Phase 1/2 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡